Business Wire

The Game-Changing Wireless Mouse: Higround’s YUMA is Designed for Style and Performance

9.9.2024 22:50:00 CEST | Business Wire | Press release

Share

Higround, the premier lifestyle and graphic gaming peripheral brand, is thrilled to announce its first-ever wireless gaming mouse: YUMA. Lightweight, meticulously designed, and built to perform, YUMA marks a new chapter in Higround’s mission to elevate every aspect of your gaming setup into a true expression of individual artistry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909711165/en/

The YUMA mouse launches with two colorways: RADAR and CELSHADE. (Photo: Business Wire)

Meet YUMA: Where Art Meets Performance

Every wireless mouse features hand-applied graphic artwork, ensuring that each mouse is fine-tuned to the minutest detail. It’s a true collector’s item that reflects Higround’s commitment to individuality and creative expression. Weighing in at just 49 grams, YUMA is a game-changer in the world of gaming mice, combining top-tier performance with unparalleled design aesthetics. With two distinct designs—RADAR and CELSHADE—the YUMA collection brings bold, unique visuals to your fingertips.

YUMA is more than just an aesthetically pleasing mouse; it packs serious gaming performance, featuring a 4KHz wireless polling rate for ultra-responsive, lag-free gameplay. Every click and movement registers with pinpoint accuracy, giving users the competitive edge they need to rise to the top.

Equipped with a battery life of up to 70 hours, YUMA ensures you stay in the game longer without the worry of frequent recharges. Whether you’re a casual gamer or a competitive esports player, YUMA delivers the reliability and performance you need while looking incredible on your desk.

Higround's Expansion Across the Desk Setup

With the introduction of YUMA, Higround continues its mission to transform every piece of your gaming setup into a canvas for personal expression. "We started Higround with the belief that your setup is an extension of who you are," says Rustin Sotoodeh, CEO and Creative Director of Higround. "With YUMA, we’re expanding Higround’s reach onto an even more technical piece of hardware, giving gamers a mouse that not only performs at the highest level but also stands out as a unique work of art."

“We're excited to introduce our new YUMA mouse, engineered with performance in mind and infused with our distinctive visual style,” says Higorund’s Principal Product Manager, Jeff Chang. “This release marks a significant step for Higround and we can't wait to show off our unique vision to the world.”

YUMA launches with its debut designs—RADAR and CELSHADE— on September 13 at 12 PM PT exclusively on Higround.

ABOUT HIGROUND

Higround is a lifestyle and computer peripheral brand that is the expression of elevated gaming culture. Founded by Rustin Sotoodeh and Kha Lu, Higround creates high-quality peripherals with unique designs that call back to the overarching cultures of fashion, gaming, and technology. Each collection features a unique collection of items that add personality to computer setups that are known to sell out in an instant. The brand is widely known for collaborations with iconic brands such as Pokemon, Beats by Dre, and One Piece. With their expansion into mice, Higround continues its journey to take over your gaming setup—one peripheral at a time. In 2021 the brand was acquired by esports giant, 100 Thieves.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240909711165/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye